Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Cardiovascular effects of oxytocin and carbetocin at cesarean section. A prospective double-blind randomized study using noninvasive pulse wave analysis

Rabow, Sofus LU ; Jonsson, Hanna ; Bro, Emilie and Olofsson, Per LU (2023) In Journal of Maternal-Fetal and Neonatal Medicine 36(1).
Abstract

Background: Oxytocin is routinely administered after delivery for prophylaxis and treatment of postpartum hemorrhage, but it is associated with considerable cardiovascular side-effects. Carbetocin, a synthetic oxytocin analogue, has a myometrial contraction effect of 60 min when given IV, compared with 16 min for oxytocin. Objective: To investigate whether there are differences in cardiovascular effects between oxytocin and carbetocin up to 1 h after treatment. Methods: Sixty-one healthy pregnant women undergoing elective cesarean section in spinal anesthesia were randomized to receive an IV bolus of either five units (8.3 µg) of oxytocin or 100 µg of carbetocin after delivery of the baby. Heart rate (HR), mean arterial blood pressure,... (More)

Background: Oxytocin is routinely administered after delivery for prophylaxis and treatment of postpartum hemorrhage, but it is associated with considerable cardiovascular side-effects. Carbetocin, a synthetic oxytocin analogue, has a myometrial contraction effect of 60 min when given IV, compared with 16 min for oxytocin. Objective: To investigate whether there are differences in cardiovascular effects between oxytocin and carbetocin up to 1 h after treatment. Methods: Sixty-one healthy pregnant women undergoing elective cesarean section in spinal anesthesia were randomized to receive an IV bolus of either five units (8.3 µg) of oxytocin or 100 µg of carbetocin after delivery of the baby. Heart rate (HR), mean arterial blood pressure, ECG ST index, oxygen saturation (SaO2), and photoplethysmographic digital pulse wave analysis variables were recorded before and at 1, 5, 20, and 60 min after drug administration. Vasopressor use, uterine tonus, total bleeding, and need for additional uterotonics were also assessed. Repeated measurement ANOVA was used for statistical analyses. Results: The drugs had equal vasodilatory and hypotensive effects. Oxytocin, but not carbetocin, caused a decrease in HR at 1 min and a sustained decrease in cardiac left ventricular ejection time. Aggregate vasopressor use was higher in the carbetocin group. Neither drug caused any change in ST index, SaO2, or subjective cardiac symptoms. Uterine tonus, need for additional uterotonics, or total bleeding did not differ significantly between the groups. Conclusion: Single doses of oxytocin and carbetocin had similar dilatory effects on vascular tonus, where the difference in aggregate vasopressor use can be attributed to a more persistent hypotensive effect of carbetocin. A transient negative chronotropic and sustained negative inotropic effect occurred after oxytocin. Neither drug showed any alarmingly adverse effects. Differences in drug effects may be attributed to differences in oxytocin and vasopressin receptor signaling pathways.

(Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Carbetocin, cardiovascular effects, cesarean section, oxytocin, pharmacologic effects, pulse wave analysis
in
Journal of Maternal-Fetal and Neonatal Medicine
volume
36
issue
1
article number
2208252
publisher
Taylor & Francis
external identifiers
  • pmid:37150593
  • scopus:85158031919
ISSN
1476-7058
DOI
10.1080/14767058.2023.2208252
language
English
LU publication?
yes
id
a48aa7e4-6cd2-40f3-bf68-247e0c9b9252
date added to LUP
2023-08-16 12:30:07
date last changed
2024-04-20 00:44:25
@article{a48aa7e4-6cd2-40f3-bf68-247e0c9b9252,
  abstract     = {{<p>Background: Oxytocin is routinely administered after delivery for prophylaxis and treatment of postpartum hemorrhage, but it is associated with considerable cardiovascular side-effects. Carbetocin, a synthetic oxytocin analogue, has a myometrial contraction effect of 60 min when given IV, compared with 16 min for oxytocin. Objective: To investigate whether there are differences in cardiovascular effects between oxytocin and carbetocin up to 1 h after treatment. Methods: Sixty-one healthy pregnant women undergoing elective cesarean section in spinal anesthesia were randomized to receive an IV bolus of either five units (8.3 µg) of oxytocin or 100 µg of carbetocin after delivery of the baby. Heart rate (HR), mean arterial blood pressure, ECG ST index, oxygen saturation (SaO<sub>2</sub>), and photoplethysmographic digital pulse wave analysis variables were recorded before and at 1, 5, 20, and 60 min after drug administration. Vasopressor use, uterine tonus, total bleeding, and need for additional uterotonics were also assessed. Repeated measurement ANOVA was used for statistical analyses. Results: The drugs had equal vasodilatory and hypotensive effects. Oxytocin, but not carbetocin, caused a decrease in HR at 1 min and a sustained decrease in cardiac left ventricular ejection time. Aggregate vasopressor use was higher in the carbetocin group. Neither drug caused any change in ST index, SaO<sub>2</sub>, or subjective cardiac symptoms. Uterine tonus, need for additional uterotonics, or total bleeding did not differ significantly between the groups. Conclusion: Single doses of oxytocin and carbetocin had similar dilatory effects on vascular tonus, where the difference in aggregate vasopressor use can be attributed to a more persistent hypotensive effect of carbetocin. A transient negative chronotropic and sustained negative inotropic effect occurred after oxytocin. Neither drug showed any alarmingly adverse effects. Differences in drug effects may be attributed to differences in oxytocin and vasopressin receptor signaling pathways.</p>}},
  author       = {{Rabow, Sofus and Jonsson, Hanna and Bro, Emilie and Olofsson, Per}},
  issn         = {{1476-7058}},
  keywords     = {{Carbetocin; cardiovascular effects; cesarean section; oxytocin; pharmacologic effects; pulse wave analysis}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{Taylor & Francis}},
  series       = {{Journal of Maternal-Fetal and Neonatal Medicine}},
  title        = {{Cardiovascular effects of oxytocin and carbetocin at cesarean section. A prospective double-blind randomized study using noninvasive pulse wave analysis}},
  url          = {{http://dx.doi.org/10.1080/14767058.2023.2208252}},
  doi          = {{10.1080/14767058.2023.2208252}},
  volume       = {{36}},
  year         = {{2023}},
}